- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Tyrosine kinase signaling-independent MET-targeting with CAR-T cells ; volume:21 ; number:1 ; day:1 ; month:10 ; year:2023 ; pages:1-17 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (1.10.2023), 1-17, 12.2023
- Creator
-
Qin, Anna
Qin, Yuan
Lee, Joseph
Musket, Anna
Ying, Mingyao
Krenciute, Giedre
Marincola, Francesco M.
Yao, Zhi Q.
Musich, Phillip R.
Xie, Qian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04521-9
- URN
-
urn:nbn:de:101:1-2024020112412440380375
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qin, Anna
- Qin, Yuan
- Lee, Joseph
- Musket, Anna
- Ying, Mingyao
- Krenciute, Giedre
- Marincola, Francesco M.
- Yao, Zhi Q.
- Musich, Phillip R.
- Xie, Qian
- SpringerLink (Online service)
Other Objects (12)
Engineering CAR-T cells
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Engineering CAR-T cells
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Engineering CAR-T cells
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy